Latest On SANUWAVE Health, Inc (SNWV):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-24 12:50 EST | News | SANUWAVE Health appoints CEO | N/A |  |
| 2023-05-12 19:45 EST | News | SANUWAVE Health GAAP EPS of -$0.02, revenue of $3.8M | N/A | |
| 2022-11-15 14:16 EST | News | SANUWAVE Health GAAP EPS of -$0.02, revenue of $4.2M | N/A | |
| 2022-06-07 23:33 EST | News | Sanuwave Health reports 5% sequential growth in May sales funnel: Monthly Update | N/A | |
| 2022-04-08 10:43 EST | News | SANUWAVE to share monthly performance data | N/A | |
| 2022-01-19 23:39 EST | News | SANUWAVE Health, Inc. (SNWV) CEO Kevin Richardson on Business Update Call (Transcript) | N/A | |
| 2021-09-29 08:27 EST | News | SANUWAVE Health says shares will no longer be traded on OTC market | N/A | |
| 2021-04-29 05:56 EST | News | SANUWAVE Health inks $3M private placement financing | N/A | |
| 2021-03-30 19:52 EST | News | SANUWAVE Health inks deal for sale wound care products in U.S. | N/A | |
| 2021-03-30 00:49 EST | News | SANUWAVE Health inks exclusive distribution deal with Kingdom Brother | N/A | |
| 2021-03-19 10:15 EST | News | Sanuwave Health inks distribution pact with Labb Solutions | N/A | |
| 2020-12-04 06:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 01:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 07:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-19 08:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-19 08:01 EST | Earnings Estimate | An EPS average of -$0.01 is estimated for the 2021 year. | Buy | |
| 2020-11-19 08:01 EST | Earnings Estimate | An EPS average of -$0.01 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-18 05:33 EST | News | SANUWAVE Health EPS misses by $0.01, beats on revenue | N/A | |
| 2020-10-08 21:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-16 07:17 EST | Earnings Estimate | An EPS average of -$0.03 is estimated for the 2020 year. | Sell | |
| 2020-09-16 07:17 EST | Analyst Rating | The Analyst Target Price has decreased from $6 to $0.34. | Neutral | |
| 2020-09-11 21:21 EST | News | SANUWAVE Health (SNWV) Investor Presentation - Slideshow | N/A | |
| 2020-08-16 07:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 16:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 01:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 15:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 21:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 12:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-03 07:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 23:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 07:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 20:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 04:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-29 23:25 EST | Analyst Rating | The Analyst Target Price has increased from $0 to $6. | Buy | |
| 2020-06-25 03:48 EST | News | SANUWAVE Health reports Q1 results | N/A | |
| 2020-06-25 03:48 EST | News | SANUWAVE Health, Inc. (SNWV) CEO Kevin Richardson on Q1 2020 Results - Earnings Call Transcript | N/A | |
| 2020-06-25 03:44 EST | News | Sanuwave Health to acquire Celularity’s UltraMIST | N/A | |
| 2020-06-23 11:29 EST | Insider Trade | Kevin A II Richardson has directly acquired 5,569,910 shares and currently holds 7,153,226 shares. | Buy | |
| 2020-06-23 11:29 EST | Insider Trade | Anthony Michael Stolarski has directly acquired 225,000 shares and currently holds 6,199,626 shares. | Buy | |
About SANUWAVE Health, Inc (SNWV):
SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States, Europe, Canada, Asia, and the Asia Pacific. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device that has completed its Phase III clinical studies for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. It markets and sells its devices and accessories. SANUWAVE Health, Inc. was founded in 2005 and is headquartered in Suwanee, Georgia.
General
- Name SANUWAVE Health, Inc
- Symbol SNWV
- Type Common Stock
- Exchange OTCQB
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 23
- Fiscal Year EndDecember
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://www.sanuwave.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 22.79
- Enterprise Value Revenue 39.04
View More
Financials
- Most Recent Quarter 2020-09-30
- Operating Margin -522%
- Return on Assets -48%
- Revenue 2.53 million
- Earnings Per Share -$0.05
- Revenue Per Share $0.01
- Gross Profit 489807
- Quarterly Earnings Growth 895.2%
View More
Highlights
- Market Capitalization 79.89 million
- EBITDA -7791249
- Analyst Target Price $0.34
View More
Share Statistics
- Shares Outstanding 467.2 million
- Shares Float 360.88 million
- % Held by Insiders 581%
- % Held by Institutions 7.01%
View More
Technicals
- Beta -0.42
- 52 Week High $0.3
- 52 Week Low $0.15
- 50 Day Moving Average 0.19
- 200 Day Moving Average 0.19
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
SANUWAVE Health, Inc (SNWV) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
SANUWAVE Health, Inc (SNWV) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-17 | $N/A | -$0.02 | -$0.01 | -100% |
| 2020-06-30 | 2020-08-14 | $N/A | -$0.01 | ||
| 2020-03-31 | 2020-05-15 | $148592 | -$0.01 | ||
| 2019-12-31 | 2020-03-30 | $336151 | -$0.01 | -$0.01 | 0% |
| 2019-09-30 | 2019-11-14 | $197640 | -$0.01 | -$0.02 | 50% |
| 2019-06-30 | 2019-08-14 | $316976 | -$0.02 | -$0.02 | 0% |
| 2019-03-31 | 2019-05-20 | $177963 | -$0.01 | -$0.01 | 0% |
| 2018-12-31 | 2019-03-29 | $456789 | -$0.02 | -$0.02 | 0% |
| 2018-09-30 | 2018-11-19 | $595789 | -$0.01 | -$0.02 | 50% |
| 2018-06-30 | 2018-08-14 | $453210 | -$0.02 | -$0.02 | 0% |
| 2018-03-31 | 2018-05-15 | $344272 | -$0.04 | -$0.01 | -300% |
| 2017-12-31 | 2018-03-29 | $317000 | -$0.02 | -$0.01 | -100% |
| 2017-09-30 | 2017-11-14 | $161000 | -$0.01 | -$0.01 | 0% |
| 2017-06-30 | 2017-08-14 | $111000 | -$0.01 | -$0.01 | 0% |
| 2017-03-31 | 2017-05-15 | $150000 | $-0.00 | -$0.01 | 64% |
| 2016-12-31 | 2017-03-31 | $648000 | -$0.02 | -$0.01 | -100% |
| 2016-09-30 | 2016-11-08 | $255000 | -$0.01 | -$0.01 | 5% |
| 2016-06-30 | 2016-08-15 | $204000 | -$0.01 | -$0.01 | 0% |
| 2016-03-31 | 2016-05-17 | $269000 | -$0.02 | -$0.02 | 0% |
| 2015-12-31 | 2016-03-30 | $372000 | -$0.02 | -$0.02 | 0% |
| 2015-09-30 | 2015-11-12 | $144000 | -$0.02 | ||
| 2015-06-30 | 2015-08-11 | $240000 | -$0.02 | ||
| 2015-03-31 | 2015-05-06 | $210000 | -$0.02 | ||
| 2014-12-31 | 2015-03-03 | $236000 | $-0.00 | ||
| 2014-09-30 | 2014-11-12 | $228000 | -$0.03 | ||
| 2014-06-30 | 2014-08-06 | $238000 | -$0.04 | ||
| 2014-03-31 | 2014-05-14 | $145000 | -$0.06 | ||
| 2013-09-30 | 2013-11-12 | $148000 | -$0.14 | ||
| 2013-06-30 | 2013-08-15 | $161000 | -$0.04 | ||
| 2013-03-31 | 2013-05-15 | $201000 | -$0.25 | ||
| 2012-12-31 | 2013-03-27 | $142000 | -$0.08 | ||
| 2012-09-30 | 2012-11-12 | $178000 | -$0.07 | ||
| 2012-06-30 | 2012-08-08 | $210000 | -$0.07 | -$0.09 | 22.22% |
| 2012-03-31 | 2012-05-14 | $239000 | -$0.09 | -$0.11 | 18.18% |
| 2011-12-31 | 2012-03-14 | -$0.11 | -$0.10 | -10% | |
| 2011-09-30 | 2011-11-14 | -$0.10 | -$0.13 | 23.08% | |
| 2011-06-30 | 2011-08-10 | -$0.17 | -$0.22 | 22.73% | |
| 2011-03-31 | 2011-05-16 | -$0.14 | |||
| 2010-12-31 | 2010-12-31 | -$0.51 | |||
| 2010-09-30 | 2010-09-30 | -$0.21 | |||
| 2010-06-30 | 2010-06-30 | -$0.22 | |||
| 2010-03-31 | 2010-03-31 | -$0.24 | |||
| 2009-12-31 | 2009-12-31 | -$0.02 | |||
| 2009-09-30 | 2009-09-30 | -$0.23 |
SANUWAVE Health, Inc (SNWV) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | 286754 | 314067 | 299903 |
| Income Before Tax | N/A | N/A | -3 million | -2.75 million | -2.75 million |
| Selling General Administrative | N/A | N/A | 2.52 million | 2.38 million | 2.14 million |
| Gross Profit | N/A | N/A | 59715 | 199885 | 74717 |
| Ebit | N/A | N/A | -2.75 million | -2.51 million | -2.37 million |
| Operating Income | N/A | N/A | -2.8 million | -2.53 million | -2.39 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | N/A | 148592 | 336151 | 197640 |
| Cost of Revenue | N/A | N/A | 88877 | 136266 | 122923 |
| Total Other Income Expense Net | N/A | N/A | -4023 | -13780 | -4840 |
| Net Income From Continuing Operations | N/A | N/A | -3 million | -2.75 million | -2.75 million |
| Net Income Applicable to Common Shares | -6.18 million | -3.63 million | -3 million | -2.75 million | -2.75 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -18.92 million | N/A | -4855 | -24949 | -3151 |
| Change to Liabilities | N/A | 671649 | -345696 | 259555 | 202757 |
| Total Cash Flow from Investing Activities | N/A | -1.11 million | -4855 | -24949 | -3151 |
| Net Borrowings | N/A | 1.67 million | -28055 | -58687 | 1.56 million |
| Total Cash Flow from Financial Activities | 29.15 million | N/A | 2.23 million | 3.12 million | 1.54 million |
| Change to Operating Activities | N/A | 316206 | 248753 | 671289 | 361212 |
| Change in Cash | 4.96 million | N/A | -413563 | 1.36 million | 248210 |
| Total Cash from Operating Activities | -5.27 million | -1.87 million | -2.65 million | -1.73 million | -1.3 million |
| Depreciation | 329947 | N/A | 49911 | 36461 | 11175 |
| Other Cash Flow from Investing Activities | N/A | -1.11 million | N/A | N/A | N/A |
| Change to Inventory | -28166 | N/A | 24188 | -252019 | 132996 |
| Change to Account Receivables | -1.06 million | N/A | -111374 | -205901 | 162816 |
| Other Cash Flow from Financing Activities | N/A | 150000 | N/A | N/A | N/A |
| Change to Net Income | N/A | 883336 | 486775 | 519939 | 567922 |
| Capital Expenditures | 34287 | N/A | 4855 | 24949 | 3151 |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 15.68 million | 13.45 million | 14.96 million |
| Total Stockholder Equity | N/A | N/A | -12.56 million | -10.06 million | -13.32 million |
| Other Current Liabilities | 6.51 million | N/A | N/A | N/A | 1.16 million |
| Total Assets | N/A | N/A | 3.12 million | 3.38 million | 1.64 million |
| Common Stock | 466095 | 302119 | 297664 | 293781 | 245768 |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -143.04 million | -132.39 million | -128.75 million | -125.75 million | -123 million |
| Other Liabilities | 45519 | 53782 | 61938 | 573224 | 61179 |
| Other Assets | 31010 | 1.15 million | 43096 | 41931 | 30058 |
| Cash | N/A | N/A | 1.35 million | 1.76 million | 402656 |
| Total Current Liabilities | 19.72 million | N/A | 12.89 million | 12.42 million | 14.54 million |
| Other Stockholder Equity | -61365 | -64157 | -57408 | -62234 | -49716 |
| Property, Plant & Equipment | 1.42 million | 834315 | 874941 | 835703 | 656227 |
| Total Current Assets | 9.95 million | N/A | 2.2 million | 2.5 million | 958018 |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -21.01 million | -14.82 million | -12.56 million | -10.06 million | -13.32 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 2.54 million | N/A | 518767 | 542955 | 290936 |
| Accounts Payable | 2.32 million | N/A | 1.12 million | 1.44 million | 1.7 million |
SANUWAVE Health, Inc (SNWV) Chart:
SANUWAVE Health, Inc (SNWV) News:
Below you will find a list of latest news for SANUWAVE Health, Inc (SNWV) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
SANUWAVE Health, Inc (SNWV) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
SANUWAVE Health, Inc (SNWV) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1417663/000114036120014893/0001140361-20-014893-index.htm |
| 2020-06-09 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1417663/000114036120013424/0001140361-20-013424-index.htm |
| 2020-06-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1417663/000114036120014893/0001140361-20-014893-index.htm |
| 2020-10-05 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1417663/000114036120022459/0001140361-20-022459-index.htm |
| 2020-08-21 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1417663/000141766320000001/0001417663-20-000001-index.htm |
| 2020-01-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1417663/000149315220000883/0001493152-20-000883-index.htm |
| 2019-08-15 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1417663/000165495419009653/0001654954-19-009653-index.htm |
| 2019-08-15 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1417663/000165495419009655/0001654954-19-009655-index.htm |
| 2019-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495419009743/0001654954-19-009743-index.htm |
| 2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1417663/000165495419010088/0001654954-19-010088-index.htm |
| 2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1417663/000165495419010089/0001654954-19-010089-index.htm |
| 2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1417663/000165495419010090/0001654954-19-010090-index.htm |
| 2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1417663/000165495419010091/0001654954-19-010091-index.htm |
| 2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1417663/000165495419010092/0001654954-19-010092-index.htm |
| 2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1417663/000165495419010093/0001654954-19-010093-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1417663/000165495419012341/0001654954-19-012341-index.htm |
| 2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1417663/000165495419013014/0001654954-19-013014-index.htm |
| 2019-11-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495419013120/0001654954-19-013120-index.htm |
| 2019-11-18 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1417663/000165495419013129/0001654954-19-013129-index.htm |
| 2019-11-19 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1417663/000165495419013153/0001654954-19-013153-index.htm |
| 2019-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495419013820/0001654954-19-013820-index.htm |
| 2019-12-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495419014261/0001654954-19-014261-index.htm |
| 2020-01-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420000832/0001654954-20-000832-index.htm |
| 2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420001186/0001654954-20-001186-index.htm |
| 2020-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420001397/0001654954-20-001397-index.htm |
| 2020-02-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1417663/000165495420001827/0001654954-20-001827-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1417663/000165495420001900/0001654954-20-001900-index.htm |
| 2020-03-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1417663/000165495420003538/0001654954-20-003538-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420003774/0001654954-20-003774-index.htm |
| 2020-04-17 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1417663/000165495420004197/0001654954-20-004197-index.htm |
| 2020-04-17 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1417663/000165495420004201/0001654954-20-004201-index.htm |
| 2020-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420004339/0001654954-20-004339-index.htm |
| 2020-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1417663/000165495420005608/0001654954-20-005608-index.htm |
| 2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420005711/0001654954-20-005711-index.htm |
| 2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420005717/0001654954-20-005717-index.htm |
| 2020-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420005846/0001654954-20-005846-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420006006/0001654954-20-006006-index.htm |
| 2020-05-27 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1417663/000165495420006012/0001654954-20-006012-index.htm |
| 2020-05-27 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1417663/000165495420006014/0001654954-20-006014-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420006201/0001654954-20-006201-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420006462/0001654954-20-006462-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420006523/0001654954-20-006523-index.htm |
| 2020-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420007965/0001654954-20-007965-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420008651/0001654954-20-008651-index.htm |
| 2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420008911/0001654954-20-008911-index.htm |
| 2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420008927/0001654954-20-008927-index.htm |
| 2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420008960/0001654954-20-008960-index.htm |
| 2020-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1417663/000165495420009200/0001654954-20-009200-index.htm |
| 2020-08-21 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1417663/000165495420009425/0001654954-20-009425-index.htm |
| 2020-04-22 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1417663/999999999520000821/9999999995-20-000821-index.htm |
| 2020-04-22 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1417663/999999999520000825/9999999995-20-000825-index.htm |
SANUWAVE Health, Inc (SNWV) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of SANUWAVE Health, Inc (SNWV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 581%Institutional Ownership: 701%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-11-04 | Shri P. Parikh | President | Buy | 1,000,000.00 | 0.11 | 110,000.00 | 1,000,000.00 | https://www.sec.gov/Archives/edgar/data/1417663/000165495419012341/0001654954-19-012341-index.htm |
| 2019-08-28 | Anthony Michael Stolarski | Director | Buy | 10,811,864.00 | 0.11 | 1,189,305.04 | 17,011,490.00 | https://www.sec.gov/Archives/edgar/data/1417663/000165495419010090/0001654954-19-010090-index.htm |
| 2019-04-24 | Anthony Michael Stolarski | Director | Buy | 225,000.00 | 0.08 | 18,000.00 | 6,199,626.00 | https://www.sec.gov/Archives/edgar/data/1417663/000165495419010090/0001654954-19-010090-index.htm |
| 2019-08-28 | Kevin A II Richardson | Chief Executive Officer | Buy | 5,569,910.00 | 0.11 | 612,690.10 | 7,153,226.00 | https://www.sec.gov/Archives/edgar/data/1417663/000165495419010089/0001654954-19-010089-index.htm |